References
Westphal J-F, Brogard J-M. Biliary tract infections: a guide to drug treatment. Drugs 1999 Jan; 57(1): 81–91
Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg 1994; 8: 139–45
Gerecht WB, Henry NK, Hoffman WW, et al. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med 1989; 149: 1279–84
Desai TK, Tsang TK. Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med 1988; 85: 47–50
Chamberland S, Lécuyer J, Lessard C, et al. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. Clin Infect Dis 1992; 15: 615–28
Leung JW, Cotton PB. Endoscopic nasobiliary catheter drainage in biliary and pancreatic disease. Am J Gastroenterol 1991; 86: 389–94
Van den Hazel SJ, Speelman P, Tytgat GN, et al. Successful treatment of recurrent cholangitis with antibiotic maintenance therapy. Eur J Clin Microbiol Infect Dis 1994; 13: 662–5
Meijer WS, Schmitz PI, Jeekel J. Meta-analysis of randomized controlled clinical trials of antibiotic prophylaxis in biliary tract surgery. Br J Surg 1990; 77: 283–90
Motte S, Deviere J, Dumonceau JM, et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991; 101: 1374–81
Rights and permissions
About this article
Cite this article
Empirical antibacterial treatment for biliary tract infections. Drugs Ther. Perspect 14, 5–7 (1999). https://doi.org/10.2165/00042310-199914040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199914040-00002